Sinovac Biotech extends termination date of going-private deal
Essential IR Insights Newsletter Fall - 2023
A Corporation Clearly Pinpoints Activist Investor Activity
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Sinovac Biotech Ltd. extended the termination date of its going-private deal to April 26.
The original termination date was March 26.
The Beijing-based biopharmaceutical company agreed to go private in a $400 million transaction in June 2017. The transaction initially was expected to close in the second half of 2017.
